Several brokerages have updated their recommendations and price targets on shares of RedHill Biopharma Ltd – (NASDAQ: RDHL) in the last few weeks: 9/29/2015 – RedHill Biopharma Ltd – was upgraded by analysts at Zacks from a “sell” rating to a “hold” rating. According to Zacks, “RedHill Biopharma Ltd. is an emerging Israeli biopharmaceutical company […]
